# Treatment of Postsphincterotomy Bleeding With a Novel Self-assembling Peptide Hemostatic Gel.

> **NCT05886127** · — · UNKNOWN · sponsor: **General University Hospital, Prague** · enrollment: 80 (estimated)

## Conditions studied

- Biliary Obstruction
- Complication of Treatment

## Interventions

- **DEVICE:** A novel hemostatic agent (Purastat®)

## Key facts

- **NCT ID:** NCT05886127
- **Lead sponsor:** General University Hospital, Prague
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-10-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05886127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05886127, "Treatment of Postsphincterotomy Bleeding With a Novel Self-assembling Peptide Hemostatic Gel.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05886127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*